Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial

International Journal of Cardiology

Volumn 243, Issue , 2017, Pages 110-115

  Morice, Marie Claude ^a   Talwar, Suneel ^b   Gaemperli, Oliver ^c   Richardt, Gert ^d   Eberli, Franz ^e   Meredith, Ian ^f   Zaman, Azfar ^g   Fajadet, Jean ^h   Copt, Samuel ⁱ   Greene, Samantha ⁱ   Urban, Philip ^j  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d Herzzentrum Segeberger Kliniken   (Germany)

^e TRIEMLI HOSPITAL   (Switzerland)

^f MONASH UNIVERSITY   (Australia)

^g FREEMAN HOSPITAL   (United Kingdom)

^h CLINIQUE PASTEUR   (France)

ⁱ Biosensors International   (Switzerland)

^j LA TOUR HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BIVALIRUDIN; HIRUDIN DERIVATIVE; METAL; PEPTIDE FRAGMENT; RAPAMYCIN; RECOMBINANT PROTEIN;

AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BARE METAL STENT; BLEEDING; CHRONIC KIDNEY FAILURE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE SAFETY; DRUG ELUTING CORONARY STENT; FEMALE; GERIATRIC PATIENT; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; TREND STUDY; ADVERSE DEVICE EFFECT; AGE; COMPARATIVE STUDY; DEVICES; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; MIDDLE AGED; STENT; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITHROMBINS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HIRUDINS; HUMANS; MALE; METALS; MIDDLE AGED; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; RECOMBINANT PROTEINS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 85020076704     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.04.079     Document Type: Article

References (41)

1. Alexander, K.P., Newby, L.K., Cannon, C.P., Armstrong, P.W., Gibler, W.B., Rich, M.W., Van de Werf, F., White, H.D., Weaver, W.D., Naylor, M.D., Gore, J.M., Krumholz, H.M., Ohman, E.M., American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology, Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115 (2007), 2549–2569.
2. Roffi, M., Patrono, C., Collet, J.P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J.J., Borger, M.A., Brotons, C., Chew, D.P., Gencer, B., Hasenfuss, G., Kjeldsen, K., Lancellotti, P., Landmesser, U., Mehilli, J., Mukherjee, D., Storey, R.F., Windecker, S., Baumgartner, H., Gaemperli, O., Achenbach, S., Agewall, S., Badimon, L., Baigent, C., Bueno, H., Bugiardini, R., Carerj, S., Casselman, F., Cuisset, T., Erol, Ç., Fitzsimons, D., Halle, M., Hamm, C., Hildick-Smith, D., Huber, K., Iliodromitis, E., James, S., Lewis, B.S., Lip, G.Y., Piepoli, M.F., Richter, D., Rosemann, T., Sechtem, U., Steg, P.G., Vrints, C., Luis, Zamorano J., 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37 (2016), 267–315.
3. Cayla, G., Cuisset, T., Silvain, J., Leclercq, F., Manzo-Silberman, S., Saint-Etienne, C., Delarche, N., Bellemain-Appaix, A., Range, G., El Mahmoud, R., Carrié, D., Belle, L., Souteyrand, G., Aubry, P., Sabouret, P., du Fretay, X.H., Beygui, F., Bonnet, J.L., Lattuca, B., Pouillot, C., Varenne, O., Boueri, Z., Van Belle, E., Henry, P., Motreff, P., Elhadad, S., Salem, J.E., Abtan, J., Rousseau, H., Collet, J.P., Vicaut, E., Montalescot, G., ANTARCTIC investigators, Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial. Lancet 388:10055 (2016), 2015–2022.
4. Wiviott, S.D., Braunwald, E., CH, McCabe, Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.J., Ardissino, D., De Servi, S., Murphy, S.A., Riesmeyer, J., Weerakkody, G., Gibson, C.M., Antman, E.M., TRITON-TIMI 38 Investigators, Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357 (2007), 2001–2015.
5. Berger, P.B., Bhatt, D.L., Fuster, V., Steg, P.G., Fox, K.A., Shao, M., Brennan, D.M., Hacke, W., Montalescot, G., Steinhubl, S.R., Topol, E.J., CHARISMA Investigators, Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial. Circulation 121 (2010), 2575–2583.
6. Rich, M.W., Chyun, D.A., Skolnick, A.H., Alexander, K.P., Forman, D.E., Kitzman, D.W., Maurer, M.S., JB, McClurken, Resnick, B.M., Shen, W.K., Tirschwell, D.L., American Heart Association Older Populations Committee of the Council On Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council, American College of Cardiology; and American Geriatrics Society, Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. J. Am. Coll. Cardiol. 67 (2016), 2419–2440.
7. Shanmugam, V.B., Harper, R., Meredith, I., Malaiapan, Y., Psaltis, P.J., An overview of PCI in the very elderly. J. Geriatr. Cardiol. 12 (2015), 174–184.
8. Kolte, D., Khera, S., Palaniswamy, C., Mujib, M., Fonarow, G.C., Ahmed, A., Jain, D., Frishman, W.H., Aronow, W.S., Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI. Am. J. Med. 126 (2013), 1076–1083.e1.
9. Singh, M., Mathew, V., Garratt, K.N., Berger, P.B., Grill, D.E., Bell, M.R., Rihal, C.S., Holmes, D.R. Jr., Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo clinic. Am. J. Med. 108 (2000), 187–192.
10. Batchelor, W.B., Anstrom, K.J., Muhlbaier, L.H., Grosswald, R., Weintraub, W.S., O'Neill, W.W., Peterson, E.D., Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National cardiovascular network collaboration. J. Am. Coll. Cardiol. 36 (2000), 723–730.
11. Mehta, R.H., Rathore, S.S., Radford, M.J., Wang, Y., Wang, Y., Krumholz, H.M., Acute myocardial infarction in the elderly: differences by age. J. Am. Coll. Cardiol. 38 (2001), 736–741.
12. Bach, R.G., Cannon, C.P., Weintraub, W.S., Di Battiste, P.M., Demopoulos, L.A., Anderson, H.V., De Lucca, P.T., Mahoney, E.M., Murphy, S.A., Braunwald, E., The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann. Intern. Med. 141 (2004), 186–195.
13. Skolnick, A.H., Alexander, K.P., Chen, A.Y., Roe, M.T., Pollack, C.V. Jr., Ohman, E.M., Rumsfeld, J.S., Gibler, W.B., Peterson, E.D., Cohen, D.J., Characteristics, management, and outcomes of 5,557 patients age > or = 90 years with acute coronary syndromes: results from the CRUSADE initiative. J. Am. Coll. Cardiol. 49 (2007), 1790–1797.
14. Gale, C.P., Cattle, B.A., Woolston, A., Baxter, P.D., West, T.H., Simms, A.D., Blaxill, J., Greenwood, D.C., Fox, K.A., West, R.M., Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The myocardial ischaemia national audit project 2003–2010. Eur. Heart J. 33 (2012), 630–639.
15. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E. Jr., Ganiats, T.G., Holmes, D.R. Jr., Jaffe, A.S., Jneid, H., Kelly, R.F., Kontos, M.C., Levine, G.N., Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W., Zieman, S.J., ACC/AHA Task Force Members; Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), 2354–2394.
16. Authors/Task Force members, Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S.J., Jüni, P., Kappetein, A.P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.J., Richter, D.J., Schauerte, P., Sousa Uva, M., Stefanini, G.G., Taggart, D.P., Torracca, L., Valgimigli, M., Wijns, W., Witkowski, A., 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35 (2014), 2541–2619.
17. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg, P.G., James, S.K., Atar, D., Badano, L.P., Blömstrom-Lundqvist, C., Borger, M.A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A.H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M.J., Mahaffey, K.W., Valgimigli, M., van ‘t Hof, A., Widimsky, P., Zahger, D., ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 33 (2012), 2569–2619.
18. Urban, P., Abizaid, A., Chevalier, B., Greene, S., Meredith, I., Morice, M.C., Pocock, S., Rationale and design of the LEADERS FREE trial: a randomized double-blind comparison of the biofreedom drug-coated stent vs the gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy. Am. Heart J. 165 (2013), 704–709.
19. Urban, P., Meredith, I.T., Abizaid, A., Pocock, S.J., Carrié, D., Naber, C., Lipiecki, J., Richardt, G., Iñiguez, A., Brunel, P., Valdes-Chavarri, M., Garot, P., Talwar, S., Berland, J., Abdellaoui, M., Eberli, F., Oldroyd, K., Zambahari, R., Gregson, J., Greene, S., Stoll, H.P., Morice, M.C., LEADERS FREE Investigators, Polymer-free drug-coated coronary stents in patients at high bleeding risk. N. Engl. J. Med. 373 (2015), 2038–2047.
20. Mehran, R., Rao, S.V., Bhatt, D.L., Gibson, C.M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S.D., Menon, V., Nikolsky, E., Serebruany, V., Valgimigli, M., Vranckx, P., Taggart, D., Sabik, J.F., Cutlip, D.E., Krucoff, M.W., Ohman, E.M., Steg, P.G., White, H., Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123 (2011), 2736–2747.
21. de Belder, A., de la Torre Hernandez, J.M., Lopez-Palop, R., O'Kane, P., Hernandez Hernandez, F., Strange, J., Gimeno, F., Cotton, J., Diaz Fernandez, J.F., Carrillo Saez, P., Thomas, M., Pinar, E., Curzen, N., Baz, J.A., Cooter, N., Lozano, I., Skipper, N., Robinson, D., Hildick-Smith, D., XIMA Investigators, A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA trial (Xience or vision stents for the management of angina in the elderly). J. Am. Coll. Cardiol. 63 (2014), 1371–1375.
22. Kurz, D.J., Bernheim, A.M., Tüller, D., Zbinden, R., Jeger, R., Kaiser, C., Galatius, S., Hansen, K.W., Alber, H., Pfisterer, M., Eberli, F.R., Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial. Am. Heart J. 170 (2015), 787–795.e1.
23. Psaltis, P.J., Nicholls, S.J., Management of acute coronary syndrome in the very elderly. Lancet 387 (2016), 1029–1030.
24. Sandhu, K., Nadar, S.K., Percutaneous coronary intervention in the elderly. Int. J. Cardiol. 199 (2015), 342–355.
25. Piccolo R, Magnani G, Ariotti S, Gargiulo G, Marino M, Santucci A, Franzone A, Campo G, Tebaldi M, Heg D, Windecker S, Valgimigli M. Effect of aging on ischaemic and bleeding outcomes in patients undergoing a prolonged vs. shortened duration of DAPT: insights from the PRODIGY trial. (abstract) EuroIntervention 2016 (suppl EuroPCR Abstracts 2016).
26. Wang, T.Y., Masoudi, F.A., Messenger, J.C., Shunk, K.A., Boyle, A., Brennan, J.M., Anderson, H.V., Anstrom, K.J., Dai, D., Peterson, E.D., Douglas, P.S., Rumsfeld, J.S., Percutaneous coronary intervention and drug-eluting stent use among patients ≥ 85 years of age in the United States. J. Am. Coll. Cardiol. 59 (2012), 105–112.
27. Puymirat, E., Mangiacapra, F., Peace, A., Ntarladimas, Y., Conte, M., Bartunek, J., Vanderheyden, M., Wijns, W., de Bruyne, B., Barbato, E., Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. Arch. Cardiovasc. Dis. 106 (2013), 554–561.
28. Ielasi, A., Brugaletta, S., Silvestro, A., Cequier, A., Iñiguez, A., Serra, A., Hernandez-Antolin, R., Mainar, V., Valgimigli, M., den Heijer, P., Bethencourt, A., Vazquez, N., Serruys, P., Sabate, M., Tespili, M., Everolimus-eluting stent versus bare-metal stent in elderly (≥ 75 years) versus non-elderly (< 75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial. Int. J. Cardiol. 179 (2015), 73–78.
29. Valgimigli, M., Sabaté, M., Kaiser, C., Brugaletta, S., de la Torre Hernandez, J.M., Galatius, S., Cequier, A., Eberli, F., de Belder, A., Serruys, P.W., Ferrante, G., Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ, 349, Nov 4 2014, g6427.
30. Valgimigli, M., Patialiakas, A., Thury, A., McFadden, E., Colangelo, S., Campo, G., Tebaldi, M., Ungi, I., Tondi, S., Roffi, M., Menozzi, A., de Cesare, N., Garbo, R., Meliga, E., Testa, L., Gabriel, H.M., Airoldi, F., Ferlini, M., Liistro, F., Dellavalle, A., Vranckx, P., Briguori C; ZEUS investigators. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. J. Am. Coll. Cardiol., 65(8), Mar 3 2015, 805-15.
31. Ariotti, S., Adamo, M., Costa, F., Patialiakas, A., Briguori, C., Thury, A., Colangelo, S., Campo, G., Tebaldi, M., Ungi, I., Tondi, S., Roffi, M., Menozzi, A., de Cesare, N., Garbo, R., Meliga, E., Testa, L., Gabriel, H.M., Ferlini, M., Vranckx, P., Valgimigli, M., ZEUS investigators. Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention?: a pre-specified analysis from the ZEUS trial. JACC Cardiovasc. Interv., 9(5), Mar 14 2016, 426-36.
32. Ariza-Solé, A., Formiga, F., Bernal, E., Salazar-Mendiguchía, J., Prognosis of elderly ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Am. Heart J., 168(1), 2014, e3.
33. Velders, M.A., James, S.K., Libungan, B., Sarno, G., Fröbert, O., Carlsson, J., Schalij, M.J., Albertsson, P., Lagerqvist, B., Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: a report from the Swedish coronary angiography and angioplasty registry (SCAAR) registry. Am. Heart J., 167, 2014, 666-73.
34. Mangiacapra, F., Ricottini, E., Di Gioia, G., Peace, A., Patti, G., De Bruyne, B., Wijns, W., Barbato, E., Di Sciascio, G., Comparison among patients ≥ 75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents. Am. J. Cardiol. 115 (2015), 1179–1184.
35. Gwon, H.C., Hahn, J.Y., Park, K.W., Song, Y.B., Chae, I.H., Lim, D.S., Han, K.R., Choi, J.H., Choi, S.H., Kang, H.J., Koo, B.K., Ahn, T., Yoon, J.H., Jeong, M.H., Hong, T.J., Chung, W.Y., Choi, Y.J., Hur, S.H., Kwon, H.M., Jeon, D.W., Kim, B.O., Park, S.H., Lee, N.H., Jeon, H.K., Jang, Y., Kim, H.S., Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the efficacy of Xience/Promus versus cypher to reduce late loss after stenting (EXCELLENT) randomized, multicenter study. Circulation 125 (2012), 505–513.
36. Kim, B.K., Hong, M.K., Shin, D.H., Nam, C.M., Kim, J.S., Ko, Y.G., Choi, D., Kang, T.S., Park, B.E., Kang, W.C., Lee, S.H., Yoon, J.H., Hong, B.K., Kwon, H.M., Jang, Y., RESET Investigators, A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following endeavor zotarolimus-eluting stent implantation). J. Am. Coll. Cardiol. 60 (2012), 1340–1348.
37. Feres, F., Costa, R.A., Abizaid, A., Leon, M.B., Marin-Neto, J.A., Botelho, R.V., King, S.B. 3rd, Negoita, M., Liu, M., de Paula, J.E., Mangione, J.A., Meireles, G.X., Castello, H.J. Jr., Nicolela, E.L. Jr., Perin, M.A., Devito, F.S., Labrunie, A., Salvadori, D. Jr., Gusmão, M., Staico, R., Costa, J.R. Jr., de Castro, J.P., Abizaid, A.S., Bhatt, D.L., OPTIMIZE Trial Investigators, Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 310 (2013), 2510–2522.
38. Cayla, G., Cuisset, T., Silvain, J., Henry, P., Leclercq, F., Carrié, D., Etienne, C.S., Belle, L., Rangé, G., Pouillot, C., Varenne, O., Van Belle, E., Boueri, Z., Motreff, P., Elhadad, S., Delarche, N., El Mahmoud, R., Vicaut, E., Collet, J.P., Montalescot, G., ANTARCTIC investigators, Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic study. Am. Heart J., 168, 2014, 674-81.
39. Fach, A., Bünger, S., Zabrocki, R., Schmucker, J., Conradi, P., Garstka, D., Fiehn, E., Hambrecht, R., Wienbergen, H., Comparison of outcomes of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention analyzed by age groups (< 75, 75 to 85, and > 85 years); (results from the Bremen STEMI registry). Am. J. Cardiol. 116 (2015), 1802–1809.
40. Lee, H.W., Cha, K.S., Ahn, J., Choi, J.C., Oh, J.H., Choi, J.H., Lee, H.C., Yun, E., Jang, H.Y., Choi, J.H., Hong, T.J., Jeong, M.H., Ahn, Y., Chae, S.C., Kim, Y.J., Korea Acute Myocardial Infarction Registry Investigators, Comparison of transradial and transfemoral coronary intervention in octogenarians with acute myocardial infarction. Int. J. Cardiol. 202 (2016), 419–424.
41. Tegn, N., Abdelnoor, M., Aaberge, L., Endresen, K., Smith, P., Aakhus, S., Gjertsen, E., Dahl-Hofseth, O., Ranhoff, A.H., Gullestad, L., Bendz, B., After Eighty study investigators, Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (after eighty study): an open-label randomised controlled trial. Lancet 387 (2016), 1057–1065.